Restrictions On Avandia (Rosiglitazone) Should Be Loosened, Says FDA Panel
Most of the 26-member advisory FDA panel voted to loosen the restrictions which were placed on GSK’s diabetes drug Avandia Source: Health News
Continue Reading →Posted in: AICHC News
Leave a Comment (0) →